跳至主要内容
临床试验/JPRN-jRCT2080221820
JPRN-jRCT2080221820未知3 期

A Long-term Administration Study of Aripiprazole in Children and Adolescents (Age: 6 to 17 Years) With Autistic Disorder

Otsuka Pharmaceutical Co., Ltd.0 个研究点开始时间: 2012年6月7日最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 6age old 至 <= 17age old(—)
性别
All

入选标准

  • 1) The patient meets Autistic disorder diagnostic criteria defined in DSM-IV-TR.
  • 2) The patient has completed the 031-11-002 study (the patient has visited the hospital during week8)
  • 3) Inpatient or outpatient status
  • 4) Othress

排除标准

  • 1) The patient is currently diagnosed with another disorder on the autism spectrum in DSMIV-TR, including Asperger's, Rett's Disorder, PDD-NOS, Childhood Disintegrative Disorder, or Fragile-X Syndrome.
  • 2) Patients who fall under a contraindication listed in the ABILIFY package insert

研究者

相似试验

A Long-term, Extended Treatment Study of... | 临床试验